Research Article
Higher Serum CCN3 Is Associated with Disease Activity and Inflammatory Markers in Rheumatoid Arthritis
Table 1
Baseline characteristics of participants in this study.
| Characteristics | RA patients | Healthy controls |
| Total (female/male) | 41 (36/5) | 45 (37/8) | Age, mean (SD) (year) | 51.7 (16.3) | 49.6 (12.1) | Duration of disease, mean (SD) (year) | 6.2 (5.6) | — | DAS28 (CRP), mean (SD) | 4.4 (1.6) | — | DAS28 (ESR), mean (SD) | 4.7 (1.7) | — | CRP (mg/l), mean (SD) | 57.5 (61.2) | 4.9 (3.8) | ESR (mm/h), mean (SD) | 49.9 (31.0) | 11.3 (9.6) | RF (IU/ml), mean (SD) | 580.2 (950.2) | 16.2 (10.9) | Anti-CCP (RU/ml), mean (SD) | 66.9 (63.8) | 12.4 (8.1) | IgG (g/l), mean (SD) | 14.5 (3.4) | 13.8 (6.4) | IgA (g/l), mean (SD) | 3.3 (1.3) | 3.0 (1.7) | IgM (g/l), mean (SD) | 1.5 (0.7) | 1.1 (2.0) | WBC (109/l), mean (SD) | 7.8 (2.4) | 6.9 (4.2) | Lym (109/l), mean (SD) | 1.8 (0.6) | 1.9 (1.1) | PLT (109/l), mean (SD) | 347.9 (102.3) | 196.3 (85.3) | Hb (g/l), mean (SD) | 111.2 (14.6) | 145.5 (21.8) |
|
|
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; anti-CCP: anti-cyclic citrullinated peptide; Ig: immunoglobulin; WBC: white blood cell; Lym: lymphocytes; PLT: platelet; Hb: hemoglobin. indicates RA vs. healthy controls (HC), . indicates RA vs. HC, . indicates RA vs. HC, . |